These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30762795)

  • 1. Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trial.
    Gao WQ; Meng XD; Sun Z
    Medicine (Baltimore); 2019 Feb; 98(7):e14540. PubMed ID: 30762795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolvaptan add-on therapy in patients with acute heart failure: A systematic review and meta-analysis.
    Luo X; Jin Q; Wu Y
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00614. PubMed ID: 32500625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of tolvaptan for heart failure in chronic kidney disease: A protocol for systematic review and meta-analysis.
    Zhu ZY; Cui M; Zhao J; Wang HY
    Medicine (Baltimore); 2022 Dec; 101(52):e32366. PubMed ID: 36596041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
    Wu MY; Chen TT; Chen YC; Tarng DC; Wu YC; Lin HH; Tu YK
    PLoS One; 2017; 12(9):e0184380. PubMed ID: 28898297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ivabradine for heart failure: A protocol for a systematic review of randomized controlled trial.
    Xue EZ; Zhang MH; Liu CL
    Medicine (Baltimore); 2019 Apr; 98(14):e15075. PubMed ID: 30946357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sacubitril valsartan sodium tablet for the treatment of chronic heart failure: A systematic review protocol of randomized controlled trials.
    Liu Z; Wang J; Li Y
    Medicine (Baltimore); 2019 Nov; 98(47):e18050. PubMed ID: 31764831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Tolvaptan in the Treatment for Patients with Autosomal Dominant Polycystic Kidney Disease: A Meta-analysis.
    Xie X; Cai Q; Guo XY; Bai DH; Sheng HZ; Wang BK; Yan K; Lu AM; Wang XR
    Comb Chem High Throughput Screen; 2020; 23(1):6-16. PubMed ID: 31793415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis.
    Wang C; Xiong B; Cai L
    BMC Cardiovasc Disord; 2017 Jun; 17(1):164. PubMed ID: 28633650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Shenmai injection for the treatment of chronic heart failure: A protocol of systematic review.
    Gao P; Wu X; Zhang FH; Qiao ZL; Yang LJ
    Medicine (Baltimore); 2020 Jun; 99(26):e20663. PubMed ID: 32590740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolvaptan for Volume Management in Heart Failure.
    Gunderson EG; Lillyblad MP; Fine M; Vardeny O; Berei TJ
    Pharmacotherapy; 2019 Apr; 39(4):473-485. PubMed ID: 30802995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tolvaptan add-on therapy in patients with acute heart failure: meta-analysis on randomised controlled trials.
    Ma G; Ma X; Wang G; Teng W; Hui X
    BMJ Open; 2019 May; 9(4):e025537. PubMed ID: 31048435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Linggui Zhugan decoction in the treatment of chronic heart failure with Yang deficiency: A protocol for systematic review and meta-analysis.
    Li Y; Wu H; Zhang B; Xu X; Wang Y; Song Q
    Medicine (Baltimore); 2021 May; 100(20):e26012. PubMed ID: 34011101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy and safety of tolvaptan on treating heart failure patients with hyponatremia].
    Li L; Bai H; Zhu WL;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):936-40. PubMed ID: 22321279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims database.
    Imai S; Momo K; Kashiwagi H; Sato Y; Miyai T; Sugawara M; Takekuma Y
    Expert Opin Drug Saf; 2021 Oct; 20(10):1257-1266. PubMed ID: 34225550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Tolvaptan in Patients More Than 90 Years Old With Acute Heart Failure.
    Sato Y; Uzui H; Mukai M; Shiomi Y; Hasegawa K; Ikeda H; Tama N; Fukuoka Y; Morishita T; Ishida K; Kaseno K; Miyazaki S; Nakano A; Tada H
    J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):47-56. PubMed ID: 31280620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective Observational Study on Predictors of Body Weight and BNP Teduction in Cases of Tolvaptan Induction for Heart Failure].
    Shinoda R; Shinoda Y; Mori T; Yoshimura T
    Yakugaku Zasshi; 2021; 141(2):281-288. PubMed ID: 33518649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial.
    Hu J; Wan Q; Zhang Y; Zhou J; Li M; Jiang L; Yuan F
    BMC Cardiovasc Disord; 2020 Oct; 20(1):447. PubMed ID: 33054727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tolvaptan vs. furosemide in older patients with heart failure : Meta-analysis of randomized controlled trials.
    Huang WL; Yang Y; Yang J; Yang J; Wang HB; Xiong XL; Zhang YF
    Herz; 2018 Jun; 43(4):338-345. PubMed ID: 28523370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials.
    Xiong B; Huang Y; Tan J; Yao Y; Wang C; Qian J; Rong S; Deng S; Cao Y; Zou Y; Huang J
    Heart Fail Rev; 2015 Nov; 20(6):633-42. PubMed ID: 26334632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.